Years of Service

0

APIs

0

FDFs

0

Countries with commercial presence

0

State-of-the-art manufacturing and marketing

0

Workforce united by passion, purpose & performance

Introduction to Hetero Vietnam

Introduction to Hetero Vietnam

Hetero Vietnam is a leading pharmaceutical company that commenced operations in 2017, and is a subsidiary of the Hetero Group, a global pharmaceutical leader headquartered in India. Driven by a clear and meaningful purpose, we strive to bring advanced, trusted, and affordable treatment options closer to every Vietnamese patient.
We are committed to delivering high-quality, accessible, and cost-effective pharmaceutical products across a wide range of therapeutic segments. With a strong focus on improving public health, Hetero Vietnam aims to make a meaningful and lasting impact on patients’ lives across the country.

Our Journey

From our very first steps, we have expanded steadily across key therapeutic segments, becoming a reliable partner in Vietnam’s growing healthcare landscape:

  • 2017–2018: Entered the Vietnamese market with a diverse portfolio covering Cardiology, Respiratory, Gastroenterology, Psychiatry—and notably HIV/ARV treatments.
  • 2023: Marked a significant milestone with our Oncology portfolio, offering targeted therapies that improve cancer care accessibility.
  • 2025: Sustaining our core strengths while expanding into Hospital Care and Antiviral therapies, fully aligned with the country’s public health priorities.

Milestones and Achievements

We are proud to stand alongside Vietnamese patients, offering high-quality treatment options at accessible prices. Since 2017, Hetero Vietnam has:

  • Delivered products manufactured under globally recognized standards such as EU-GMP, US-FDA, or equivalent international standards.
  • Empowered more Vietnamese patients to access ARV and Oncology treatments through national health insurance coverage and targeted support initiatives.

Comprehensive Product Portfolio

Hetero Vietnam has successfully registered and commercialized over 90 active ingredients, serving a broad spectrum of therapeutic areas such as:

Oncology

HIV/ARV antivirals

Cardiology

Pain management

Psychiatry

Antibiotics

Gastroenterology

Men’s health

Respiratory & anti-allergy

Flagship Products

Quality Meets Commercial Excellence

At Hetero Vietnam, quality is a commitment we uphold everyday. We operate with the highest levels of ethics, transparency, and a patient-centric approach, ensuring that both healthcare professionals and patients have access to reliable and affordable therapies. From sourcing and production to medical engagement, we adhere to stringent global standards, maintaining integrity and compliance at every step.

Innovation & Leadership

Our commitment to innovation is reflected in our diverse product portfolio, many of which are first generic version in Vietnam and high-impact medicines across key therapeutic areas:

  • Oncology: Afatin, Nicmel, Sorafenib, Linadex, Temotero, Zoled, Bicamed, Cisplatin, Gemcitabine
  • Antivirals: Tenof EM, DLT
  • Cardiology: Apixtra, Telsar/Telsar-H, Hypolip, Ezetimibe
  • Pain Management: Celofin, Etoricoxib
  • Gastroenterology: Pantin, Yesom
  • Men’s Health: Sife, Tadafil
  • Respiratory – Antibiotics – Anti-allergy: Levin, Lazine, Monte-H
  • Hospital Care: Sugamedex, Vanconex

Each product represents our lasting commitment to provide timely, effective, and affordable solutions that improve patient outcomes and strengthen Vietnam’s healthcare system.

Career Opportunities

Why Choose Hetero Vietnam?

  • A meaningful career that impacts patient health and public well-being.
  • Comprehensive training and career-growth programs
  • Competitive rewards aligned with industry excellence
  • A culture of teamwork and respect for every contribution
  • Shape the future of healthcare—grow with Hetero every day!

Join Us

Explore the current open positions. Connect with us on email: talent@hetero.com
to build a rewarding career at Hetero Vietnam.

Map and Directions